It's an amazing tech platform. Same holds true for the story Ginkgo Bioworks spins though we've been avoiding them as we find their business model questionable.
This is a great question! Very glad you asked. Okay so if Nanalyze made $10K last month in subscription revenues we can annualize it simply by multiplying 10K by 12 - so 120K a year annualized revenues. Companies do this to show what they could be making in the future. So if we made $1000 today then annualizing that would be $365,000 (365 days in year X daily revenues). For publicly traded stocks we use the last quarter revenues and annualize it (multiply by 4 as there are four quarters in a year) and we use that number for our simple valuation ratio. it's more responsive to growth and declining growth. Hope this makes sense! Joe P.
Thank you so much for providing critical and insightful content! I know this is not the best strategy on UA-cam for gaining a lot of clicks, but that is what distinguishes you from the majority of content creators who tend to sell a lot of nonsense. I guess it would be a wise choice for me to invest in the AI Drug Stocks though an ETF. Have you already looked at those or planning to? And have you thought about doing you own ETF (a la Cathie Wood)?
You're most welcome. Our content will always be chock full of rich insights because that's what differentiates our brand. It's what we're known for. That said, we will keep working on creating better thumbnails and compelling titles to increase click throughs and to grow this channel faster. It's a lot of work and we need to show an ROI on those efforts. As for ETFs, there aren't enough AI drug discovery companies out there to support one. At least that I'm aware of. As for our own ETF, it's a lot of work to make that happen and would require our brand to be much larger thus the need to grow this channel ;) Joe P.
Thanks Joe! I maintain we need platforms that enable new insights rather than drug delivery platforms. E.g. spatial biology platforms that collect multiomic data closer to the cell phenotype, namely proteomics and metabolomics
IMO I think TWIST is the ultimate AI medicine stock. The are like the AWS of biotech enabling fast DNA. I think that one is going to 100x if the biotech boom hits
![[048] Multivalue DB Part 1 - Pick System](http://i.ytimg.com/vi/3mJLbJPn3t0/mqdefault.jpg)
Subscribe for more content on investing in AI: ua-cam.com/users/nanalyze ❤
Fucker got me again. "Understanding the female mind"😂. Even my wife laughed at that one.
It's funny because it's true :)
understanding female mind... comedy gold:)
Glad you appreciated that :) We have to make this stuff entertaining otherwise people tune out. Finance topics are inherently boring!
Any thoughts on Cerebras filing for their upcoming IPO yesterday ? Have you guys done any content on them or plan to ?
We have an article coming out on that. Needed to wait for the S-1 to be filed first.
RXRX has one hell of a story. Perhaps the best storytellers in the market. We don't invest in stories here, but we do enjoy a good read 😂
It's an amazing tech platform. Same holds true for the story Ginkgo Bioworks spins though we've been avoiding them as we find their business model questionable.
Can someone help me with what annualized revenue means, is it annual revenue YoY revenue?
This is a great question! Very glad you asked. Okay so if Nanalyze made $10K last month in subscription revenues we can annualize it simply by multiplying 10K by 12 - so 120K a year annualized revenues. Companies do this to show what they could be making in the future. So if we made $1000 today then annualizing that would be $365,000 (365 days in year X daily revenues). For publicly traded stocks we use the last quarter revenues and annualize it (multiply by 4 as there are four quarters in a year) and we use that number for our simple valuation ratio. it's more responsive to growth and declining growth. Hope this makes sense! Joe P.
Dude, that zinger 😂
Got to keep it entertaining otherwise people will switch over to Talk Tuah. ;)
Thank you so much for providing critical and insightful content! I know this is not the best strategy on UA-cam for gaining a lot of clicks, but that is what distinguishes you from the majority of content creators who tend to sell a lot of nonsense.
I guess it would be a wise choice for me to invest in the AI Drug Stocks though an ETF. Have you already looked at those or planning to?
And have you thought about doing you own ETF (a la Cathie Wood)?
You're most welcome. Our content will always be chock full of rich insights because that's what differentiates our brand. It's what we're known for. That said, we will keep working on creating better thumbnails and compelling titles to increase click throughs and to grow this channel faster. It's a lot of work and we need to show an ROI on those efforts. As for ETFs, there aren't enough AI drug discovery companies out there to support one. At least that I'm aware of. As for our own ETF, it's a lot of work to make that happen and would require our brand to be much larger thus the need to grow this channel ;) Joe P.
Thanks Joe! I maintain we need platforms that enable new insights rather than drug delivery platforms. E.g. spatial biology platforms that collect multiomic data closer to the cell phenotype, namely proteomics and metabolomics
Good insightful comment, thank you as always Adam! Joe P.
0:12 I do not invest in any AI companies at the moment. But if AI has the capability to do this, I might consider to lmao
If AI can help me truly understand my future ex wife I'm all in. Joe P.
I’m first to watch today!
Thank you for helping the algorithm with the first comment :)
2nd
We love the support as always!
IMO I think TWIST is the ultimate AI medicine stock. The are like the AWS of biotech enabling fast DNA. I think that one is going to 100x if the biotech boom hits
Covered here: www.nanalyze.com/2024/02/twist-bioscience-major-concerns/
Even the future smartest AGI could not understand the deep of women mind 😂😅
It's funny because it's true ;)